1107 Enhancing immune responses to melanoma with the RIG-I antiviral pathway agonist SLR14

• Curtis Perry,
• Kelly Olino,
• James Clune,
• Weiwei Guo,
• Jeffrey Ishizuka,
• Alexander Frey,
• Kathryn Clulo,
• Wenyuan Ton,
• Maxine Mackie,
• Feriel Ouerghi,
• Jessica Wei,
• Mary He,
• Therese Cordero Dumit,
• Min Ding

Affiliations

Curtis Perry

5Yale University, New Haven, CT, USA

Kelly Olino

2Yale New Haven Hospital, Department of Surgical Oncology, New Haven, CT, USA

James Clune

Aff6 0000000419368710grid.47100.32Section of Plastic and Reconstructive SurgeryYale School of Medicine New Haven CT USA

Weiwei Guo

Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China

Jeffrey Ishizuka

1Yale University, New Haven, CT, USA

Alexander Frey

1Yale University, New Haven, CT, USA

Kathryn Clulo

1Yale University, New Haven, CT, USA

Wenyuan Ton

1Yale University, New Haven, CT, USA

Maxine Mackie

1Yale University, New Haven, CT, USA

Feriel Ouerghi

1Yale University, New Haven, CT, USA

Jessica Wei

1Yale University, New Haven, CT, USA

Mary He

1Yale University, New Haven, CT, USA

Therese Cordero Dumit

1Yale University, New Haven, CT, USA

Min Ding

1Yale University, New Haven, CT, USA